Skip to main content

Month: July 2021

CSX Files Expanded Application with Surface Transportation Board to Acquire Pan Am Railways

JACKSONVILLE, Fla., July 02, 2021 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) today announced that it submitted an amended and supplemented application to the Surface Transportation Board (STB) as part of the previously announced agreement to acquire New England’s Pan Am Railway’s Inc. (Pan Am). The amended application provides all of the additional details of the proposed transaction requested by the STB in their May 26, 2021 ruling. James M. Foote, president and chief executive officer of CSX said: “CSX is pleased to submit an expanded application for the acquisition of Pan Am Railways, which explains the tremendous benefits of the proposed transaction for stakeholders in New England and beyond. “The proposed transaction is an “end-to-end” acquisition that will integrate the New England rail network owned by Pan Am into CSX’s...

Continue reading

BioSig Announces Pricing of Public Offering of Common Stock

Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced pricing of its previously announced underwritten public offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. The gross proceeds to BioSig from this offering are expected to be approximately $10 million, or approximately $11.5 million if the underwriter exercises its 30-day option to purchase an additional 15% of the number of shares of common stock offered in the public offering in full, before deducting the underwriting discounts and commissions...

Continue reading

LexaGene Advances Towards FDA Emergency Use Authorization

BEVERLY, Mass., July 02, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced it continues to systematically advance the MiQLab™ System to meet the Food and Drug Administration (FDA) criteria for Emergency Use Authorization (EUA). The MiQLab System is a first of its kind, point of care diagnostic testing technology. The FDA EUA process requires novel diagnostic devices to undergo a substantial amount of complex design control and testing. All functions for critical system operation must be validated and submitted as part of the process. Dr. Jack Regan, LexaGene’s Founder and CEO, stated, “The MiQLab systems we’ve sold into veterinary diagnostics and the biologics manufacturing market...

Continue reading

Bombardier Announces Expiration of its Cash Tender Offer for Certain Outstanding Senior Notes

MONTRÉAL, July 02, 2021 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier” or the “Corporation”) announced today that its cash tender offer previously announced on June 3, 2021 (as amended by the Corporation’s press release dated June 17, 2021 and as further amended by the Corporation’s press release dated June 25, 2021, the “Tender Offer”) to purchase for cash up to US$1,000,000,000 aggregate purchase price (exclusive of Accrued Interest) (the “Aggregate Maximum Purchase Amount”) of three series of its outstanding senior notes (collectively, “Notes”) due 2022 and 2023 as identified in the Offer to Purchase (as defined below), expired at the Expiration Date, 11:59 P.M., New York City time, on July 1, 2021. Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Offer to Purchase dated June...

Continue reading

Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases

Alector and GSK to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases, including frontotemporal dementia, amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease Companies will co-commercialize and share profits in the US; GSK will retain exclusive commercialization rights outside the US Alector will receive $700 million in upfront payments, up to $1.5 billion in potential milestone payments, profit sharing and royalties Alector management to host conference call today at 8:30 a.m. ETSOUTH SAN FRANCISCO, Calif. and LONDON, July 02, 2021 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC) and GlaxoSmithKline plc (LSE/NYSE: GSK), today announced a strategic global collaboration for the development and commercialization of two clinical-stage, potential...

Continue reading

Icanic Brands Closes Acquisition of De Krown Enterprises LLC

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 02, 2021 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator in California and Nevada, is pleased to announce that it has closed the previously announced acquisition of De Krown Enterprises LLC (“De Krown”), a California-based leading cannabis manufacturing partner and brand owner. De Krown is led by a team of successful and tenured executives from the California cannabis space as well as proven entrepreneurs in various other fields. De Krown currently manufacturers for some of California’s premier cannabis companies including Pure Beauty, Next Green Wave, Kolas, Dahlia Capital, Cali Innovations, Smoakland, Kush Boys, Tyson...

Continue reading

Plug Power Named to Food Logistics’ Top Green Providers List for Fifth Year in a Row

LATHAM, N.Y., July 02, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, has been named to the Top Green Providers list for 2021 by Food Logistics, the only publication exclusively dedicated to covering the movement of product through the global cold food supply chain. Food Logistics’ annual Top Green Providers recognizes companies whose products, services or exemplary leadership is enhancing sustainability within the cold food and beverage industry. The editorial staff evaluates a company’s participation in such programs as the EPA’s SmartWay and other recognized sustainability programs; facilities that are LEED-certified and/or feature solar panels, LED lighting and other energy saving installations and retrofits; and other means of producing...

Continue reading

Superior Group of Companies Announces Promotions of Philip Koosed and Jake Himelstein

SEMINOLE, Fla., July 02, 2021 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC), is excited to announce two promotions, effective immediately, among its executive team. Philip Koosed, who is the Founder of BAMKO® and has served as its President, is promoted to Chief Strategy Officer of Superior Group of Companies. Jake Himelstein, who has served as the Chief Operating Officer and Chief Financial Officer of BAMKO, is promoted to President of BAMKO. “This is an important and momentous day for Phil, Jake, and the entire company,” said Michael Benstock, CEO of SGC. “In welcoming a new member into the C-Suite, we are bringing in a dynamic leader with a proven track record of growth, vision, and an ability to execute.” In his role as Chief Strategy Officer, Koosed will be supporting all of SGC, including BAMKO, by providing...

Continue reading

Troilus Gold Announces the Retirement of President Paul Pint

TORONTO, July 02, 2021 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG) (OTCQB: CHXMF) (“Troilus” or the “Company”) announces that Paul Pint, President and co-founder of the Company, has retired from Troilus effective July 1, 2021. Justin Reid, CEO, will be assuming the duties of President and CEO going forward. “On behalf of the Board of Directors and all Troilus employees and stakeholders, I would like to thank Paul for his commitment and dedication to Troilus. Paul has been instrumental in the development of the team, asset and shareholder base, now defining one of the largest gold and copper assets in Canada. Personally, Paul has been a loyal, driven and dedicated business partner for over a decade; his efforts have been a large part of our success to date. The Troilus team wishes Paul and his family all the best and much success...

Continue reading

Lerøy Seafood Group ASA: Assigned investment grade rating with a stable outlook from Nordic Credit Rating

Nordic Credit Rating (NCR) said today that it has assigned a “BBB” long-term issuer credit rating to Lerøy Seafood ASA with a stable outlook. NCR states “The rating reflects Lerøy Seafood Group ASA relatively strong market position in the profitable salmon farming industry. It also reflects the breadth of its operations as a fully integrated seafood producer with significant wildcatch, processing and distribution capabilities. It further reflects the company’s moderate financial leverage and strong cash flow, which will allow it to maintain a high level of investment, if necessary, to keep up with technological developments and create revenue growth.” The credit reports from Nordic Credit Rating can be found here: https://nordiccreditrating.com/issuer/leroy-seafood-group-asa For queries, please contact: Sjur S. Malm, CFO Lerøy Seafood...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.